Načítá se...
Plazomicin Retains Antibiotic Activity against Most Aminoglycoside Modifying Enzymes
Plazomicin is a next-generation, semisynthetic aminoglycoside antibiotic currently under development for the treatment of infections due to multidrug-resistant Enterobacteriaceae. The compound was designed by chemical modification of the natural product sisomicin to provide protection from common am...
Uloženo v:
| Vydáno v: | ACS Infect Dis |
|---|---|
| Hlavní autoři: | , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6167752/ https://ncbi.nlm.nih.gov/pubmed/29634241 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsinfecdis.8b00001 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|